{
  "id": "52dba2298f13b1e9",
  "title": "Cytokinetics , Incorporated : Cytokinetics Announces European Commission Approval of MYQORZO ( aficamten ) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy",
  "description": "20260217T184500Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-02/67718835-cytokinetics-incorporated-cytokinetics-announces-european-commission-approval-of-myqorzo-aficamten-for-the-treatment-of-adults-with-symptomatic-ob-399.htm",
  "published_at": "20260217T184500Z",
  "fetched_at": "2026-02-18T00:30:07.542614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-02/67718835-cytokinetics-incorporated-cytokinetics-announces-european-commission-approval-of-myqorzo-aficamten-for-the-treatment-of-adults-with-symptomatic-ob-399.htm",
    "url_mobile": "",
    "title": "Cytokinetics , Incorporated : Cytokinetics Announces European Commission Approval of MYQORZO ( aficamten ) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy",
    "seendate": "20260217T184500Z",
    "socialimage": "https://www.finanznachrichten.de/chart-cytokinetics-inc-aktie-intraklein-tradegate.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}